Literature DB >> 15292348

Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels.

Antje Böttner1, Jürgen Kratzsch, Grit Müller, Thomas M Kapellen, Susann Blüher, Eberhard Keller, Matthias Blüher, Wieland Kiess.   

Abstract

Adiponectin is an adipocytokine with profound antidiabetic and antiatherogenic effects that is decreased in obesity. With the increasing prevalence of obesity and the emergence of related disorders, including type 2 diabetes in children, the regulation of adiponectin and its relationship to childhood obesity is of great interest. In this study we aimed to elucidate the impact of gender, pubertal development, and obesity on adiponectin levels in children. We investigated two phenotypically characterized cohorts of 200 normal weight and 135 obese children and adolescents covering a wide range of age (3.4-17.9 yr) and body mass index (-2.1 to +4.8 sd score). In healthy lean boys, adiponectin levels significantly declined in parallel with physical and pubertal development, subsequently leading to significantly reduced adiponectin levels in adolescent boys compared with girls (5.6 +/- 0.5 vs. 7.1 +/- 0.5 mg/liter; P = 0.03). This decline was inversely related to testosterone (r = -0.42; P < 0.0001) and dehydroepiandrosterone sulfate (r = -0.20; P = 0.0068) serum concentrations and may account for the gender differences seen in adults. Using a stepwise forward multiple regression model, pubertal stage was the strongest independent predictor of adiponectin (r(2) = 0.206; P < 0.0001), with additional influences of body mass index sd score and testosterone. Adiponectin levels were decreased in obese children and adolescents compared with lean peers of corresponding age and pubertal stage (5.18 vs. 7.13 mg/liter; P = 0.015). In obese children, adiponectin levels were closely associated with parameters related to the metabolic syndrome, such as insulin resistance, hyperinsulinemia, blood pressure, and uric acid, in univariate and multivariate analyses, with the insulin sensitivity index being the strongest independent parameter identified by stepwise forward multiple regression (r(2) = 0.226; P < 0.0001). Hence, there is a strong association of adiponectin serum concentrations with obesity, pubertal development, and metabolic parameters in children indicating epidemiological and pathophysiological relevance already in childhood.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292348     DOI: 10.1210/jc.2004-0303

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  109 in total

1.  Relationships between markers of vascular dysfunction and neurodevelopmental outcomes in perinatally HIV-infected youth.

Authors:  Suad Kapetanovic; Erin Leister; Sharon Nichols; Tracie Miller; Katherine Tassiopoulos; Rohan Hazra; Harris A Gelbard; Kathleen M Malee; Betsy Kammerer; Armando J Mendez; Paige L Williams
Journal:  AIDS       Date:  2010-06-19       Impact factor: 4.177

Review 2.  Adipokines as novel biomarkers and regulators of the metabolic syndrome.

Authors:  Yingfeng Deng; Philipp E Scherer
Journal:  Ann N Y Acad Sci       Date:  2010-11       Impact factor: 5.691

3.  C-reactive protein in adolescent twins: patterns and relationship to adiposity.

Authors:  Guoying Wang; Katherine Kaufer Christoffel; Wendy J Brickman; Xiumei Hong; Lester Arguelles; Shanchun Zhang; Binyan Wang; Zhiping Li; Houxun Xing; Gengfu Tang; Donald Zimmerman; Xiping Xu; Xiaobin Wang
Journal:  J Clin Endocrinol Metab       Date:  2011-08-10       Impact factor: 5.958

4.  Genetic determination of adiponectin and its relationship with body fat topography in multigenerational families of African heritage.

Authors:  Iva Miljkovic-Gacic; Xiaojing Wang; Candace M Kammerer; Clareann H Bunker; Victor W Wheeler; Alan L Patrick; Lewis H Kuller; Rhobert W Evans; Joseph M Zmuda
Journal:  Metabolism       Date:  2007-02       Impact factor: 8.694

5.  Association of sequence variations in the gene encoding adiponectin receptor 1 (ADIPOR1) with body size and insulin levels. The Finnish Diabetes Prevention Study.

Authors:  N Siitonen; L Pulkkinen; U Mager; J Lindström; J G Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; J Tuomilehto; M Laakso; M Uusitupa
Journal:  Diabetologia       Date:  2006-05-25       Impact factor: 10.122

Review 6.  Systemic adiponectin malfunction as a risk factor for cardiovascular disease.

Authors:  Wayne Bond Lau; Ling Tao; Yajing Wang; Rong Li; Xin L Ma
Journal:  Antioxid Redox Signal       Date:  2011-04-20       Impact factor: 8.401

7.  Race and sex differences in small-molecule metabolites and metabolic hormones in overweight and obese adults.

Authors:  Mahesh J Patel; Bryan C Batch; Laura P Svetkey; James R Bain; Christy Boling Turer; Carol Haynes; Michael J Muehlbauer; Robert D Stevens; Christopher B Newgard; Svati H Shah
Journal:  OMICS       Date:  2013-10-11

8.  Allostatic Load as a Complex Clinical Construct: A Case-Based Computational Modeling Approach.

Authors:  J Galen Buckwalter; Brian Castellani; Bruce McEwen; Arun S Karlamangla; Albert A Rizzo; Bruce John; Kyle O'Donnell; Teresa Seeman
Journal:  Complexity       Date:  2015-12-23       Impact factor: 2.833

Review 9.  Identification and treatment of metabolic complications in pediatric obesity.

Authors:  Katie Larson Ode; Brigitte I Frohnert; Brandon M Nathan
Journal:  Rev Endocr Metab Disord       Date:  2009-09       Impact factor: 6.514

10.  Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications.

Authors:  J Frystyk; L Tarnow; T Krarup Hansen; H-H Parving; A Flyvbjerg
Journal:  Diabetologia       Date:  2005-08-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.